tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Iqvia price target raised to $220 from $180 at Evercore ISI

Evercore ISI raised the firm’s price target on Iqvia (IQV) to $220 from $180 and keeps an Outperform rating on the shares. The firm says Iqvia is riding high on an improved demand trajectory in pharma and biotech services, with strong Q2 results boosting confidence for 2025 and beyond. The positive momentum is fueled by solid R&DS revenues and better-than-expected TAS performance, particularly in analytics, consulting, and tech, Evercore adds.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1